February 10, 202615 min read

Synthetic DNA/Gene Synthesis Market Intelligence Report

Market Analysis
Twist Bioscience
IDT

1. Executive Summary

The synthetic DNA/gene synthesis market is dominated by two major players with distinct positioning strategies. Twist Bioscience leads with its innovative silicon-based DNA synthesis platform, offering high-throughput production capabilities and competitive pricing starting at 7¢ per base pair. The company emphasizes speed (2-4 days for gene fragments), scalability (9,600 genes per chip), and sustainability with significantly lower CO2 emissions than industry standards.

IDT (Integrated DNA Technologies) maintains a strong position through its established gBlocks gene fragment platform and comprehensive service portfolio. IDT focuses on reliability, quality assurance through ESI-MS verification, and rapid delivery (24-hour shipping for standard orders). The company targets researchers needing dependable, high-quality DNA synthesis with extensive customization options and proven track record in the market.

Both companies serve overlapping segments but with different value propositions - Twist emphasizing innovation and scale, while IDT focuses on reliability and comprehensive service offerings.

2. Company Profiles

Twist Bioscience

Market Position: Innovation leader with proprietary silicon-based synthesis technology

Company Overview: Public company (NASDAQ: TWST) headquartered in South San Francisco, focusing on synthetic biology applications through scalable DNA synthesis

Core Offerings:

  • Gene Fragments (0.3-5kb)
  • Clonal Genes with NGS verification
  • Express Genes service (4-7 day turnaround)
  • Gene Pools (pooled assembly, 300bp-1.8kb)
  • Multiplexed Gene Fragments (up to 500bp)

Target Segments:

  • Biotechnology companies
  • Pharmaceutical research
  • Academic institutions
  • Synthetic biology applications
  • High-throughput screening operations

IDT (Integrated DNA Technologies)

Market Position: Established market leader with comprehensive DNA/RNA synthesis portfolio

Company Overview: Part of Danaher Corporation, based in Coralville, Iowa, with decades of oligonucleotide synthesis expertise

Core Offerings:

  • gBlocks Gene Fragments (125-3000bp)
  • gBlocks HiFi Gene Fragments (enhanced fidelity)
  • Custom gene synthesis
  • Comprehensive oligo modifications
  • qPCR/PCR reagents and assays

Target Segments:

  • Academic research institutions
  • Clinical diagnostics
  • Pharmaceutical development
  • Biotechnology companies
  • CRISPR/gene editing applications

3. Product Comparison

FeatureTwist BioscienceIDT
Gene Fragments0.3-5kb, 7¢/bp startinggBlocks: 125-3000bp
Standard Delivery2-4 business days5-7 business days
Express OptionsExpress Genes: 4-7 daysNot specified
Quality Control1:7500 error rateESI-MS verification
Clonal GenesNGS-verified, 9¢/bp startingAvailable (pricing not disclosed)
Pooled ProductsGene Pools (0% chimera rate)Not offered
Maximum Length5kb standard3kb (gBlocks)
Production Scale9,600 genes per chipNot disclosed
SustainabilityLow CO2 emissions emphasisNot emphasized

Specialized Offerings

Twist Unique Products:

  • Gene Pools: Industry-first 0% chimera rate pooled assembly (300bp-1.8kb)
  • Multiplexed Gene Fragments: Up to 500bp for high-throughput screening
  • Express Genes: 4-7 day NGS-verified clonal genes

IDT Unique Products:

  • gBlocks HiFi: Enhanced fidelity gene fragments
  • Comprehensive modification catalog: Extensive chemical modifications
  • Integrated qPCR/CRISPR systems: Complete workflow solutions

4. Value Propositions

Twist Bioscience

Key Differentiators:

  • Silicon-based synthesis technology enabling massive parallel production
  • Industry-leading turnaround times (2-4 days standard)
  • Competitive per-base pricing with no hidden fees
  • Sustainability focus with reduced environmental impact
  • Advanced pooled synthesis capabilities

Unique Selling Points:

  • 9,600 genes synthesized simultaneously per chip
  • 0% chimera rate in Gene Pools
  • Real-time online ordering with instant feasibility feedback
  • Express service maintaining quality standards

IDT

Key Differentiators:

  • Decades of synthesis expertise and market reputation
  • Comprehensive product ecosystem (oligos to enzymes)
  • Rigorous quality control through mass spectrometry
  • Extensive modification and customization options
  • Same-day shipping for standard products

Unique Selling Points:

  • >90% of orders shipped within 24 hours
  • ESI-MS quality verification standard
  • Integrated CRISPR and qPCR workflow solutions
  • gBlocks HiFi for enhanced fidelity applications

5. Pricing Analysis

Twist Bioscience Pricing Structure

  • Gene Fragments: Starting at 7¢ USD per base pair
  • Clonal Genes: Starting at 9¢ USD per base pair
  • Express Service: Additional fee (dynamic pricing based on capacity)
  • Volume Considerations: No order limits, same turnaround regardless of size
  • No Hidden Fees: Transparent pricing with no complexity or sub-cloning fees

IDT Pricing Structure

  • Pricing: Not transparently disclosed on website
  • Quote-Based: Appears to use traditional quote-based pricing model
  • gBlocks: Pricing available through ordering system
  • Volume Discounts: Likely available but not specified

Pricing Comparison Insights

Twist's transparent, per-base-pair pricing model contrasts with IDT's traditional quote-based approach. Twist's starting prices (7-9¢/bp) appear competitive, though direct comparison requires specific quotes from IDT.

6. Market Positioning

Twist Bioscience: Innovation-Driven Premium

  • Positioning: Technology innovator with premium capabilities at competitive prices
  • Industries: Synthetic biology, high-throughput drug discovery, biotechnology
  • Geographic: Global with US manufacturing emphasis
  • Brand Promise: "You design it. We build it" - emphasizing customer design freedom

IDT: Established Reliability Leader

  • Positioning: Trusted partner with comprehensive solutions
  • Industries: Academic research, clinical diagnostics, established pharma
  • Geographic: Global with strong North American presence
  • Brand Promise: Quality, reliability, and comprehensive support

7. Competitive Insights

Twist Bioscience

Strengths:

  • Technology Leadership: Silicon-based platform enables unique capabilities
  • Speed: Industry-leading turnaround times
  • Scalability: Massive parallel synthesis capacity
  • Transparency: Clear online pricing and instant feasibility assessment
  • Innovation: Continuous development of new products (Gene Pools, Express Genes)

Weaknesses:

  • Market Maturity: Newer entrant compared to established players
  • Service Breadth: Narrower product range compared to IDT's comprehensive portfolio

IDT

Strengths:

  • Market Reputation: Decades of established relationships and trust
  • Product Breadth: Comprehensive ecosystem from oligos to complete assays
  • Quality Systems: Rigorous verification and quality control
  • Customer Support: Extensive technical support and application expertise
  • Integration: Products designed to work together across workflows

Weaknesses:

  • Innovation Pace: More conservative approach to new technology adoption
  • Pricing Transparency: Less transparent pricing model
  • Turnaround Times: Longer standard delivery times

Market Opportunities

  1. High-Throughput Applications: Growing demand for pooled synthesis and screening libraries
  2. Sustainability: Increasing focus on environmentally responsible manufacturing
  3. Speed Requirements: Accelerating research timelines driving demand for faster synthesis
  4. Cost Optimization: Pressure on research budgets favoring transparent, competitive pricing

Recommendations for Buyers

Choose Twist Bioscience if:

  • High-volume gene synthesis needs
  • Fast turnaround times are critical
  • Budget transparency is important
  • Working with challenging sequences
  • Sustainability is a consideration

Choose IDT if:

  • Need comprehensive workflow solutions
  • Require extensive customization options
  • Value established vendor relationships
  • Need integrated qPCR/CRISPR systems
  • Prioritize proven quality systems

Market Gap Opportunities

  • Mid-tier pricing options between premium and budget offerings
  • Specialized synthesis for emerging applications (epigenome editing, base editing)
  • Enhanced bioinformatics and design support tools
  • Faster international shipping and local manufacturing

The market shows healthy competition with clear differentiation strategies, benefiting customers through innovation, competitive pricing, and service improvements from both major players.

About This Report

This market intelligence report was generated using automated web scraping and AI-powered analysis. Data was collected from public company websites on February 10, 2026.